Trey Lc Oxford, MD
Interventional Cardiology · Nampa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 12
Offices
12 locations · St Lukes Clinic-Treasure Valley LLC · 1,155 clinicians in this group
Looking this up.
Hospitals listed: St Luke'S Mccall · St Luke'S Nampa Medical Center · St Luke'S Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Oxford’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Luke'S MccallMccall, IDCritical Access Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 5 of 5 · 84% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- St Luke'S Nampa Medical CenterNampa, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.25, Oct 2024 – Sep 2025
- St Luke'S Regional Medical CenterBoise, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.459, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.203, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.407, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6.8 to 9.7) · 1,092 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for St Luke'S Mccall
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 143 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 51.9 · 26 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9 to 16.9) · 374 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 78 cases | No different | Jan 2024 – Dec 2024 |
What patients said (104 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 5 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 73% |
| Yes, staff "did" give patients this information | 97% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 82% |
| Doctors "always" listened carefully | 90% |
| Doctors "always" treated them with courtesy and respect | 93% |
| Patients who gave a rating of "9" or "10" (high) | 87% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 75% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 61% |
| Yes, staff "did" give patients information about possible symptoms | 97% |
See every measure and the patient survey for St Luke'S Nampa Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.57 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.6 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,239 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,590 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,581 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.55 to 3.97) · 210 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (0.76 to 9.25) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.89) · 1,236 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.8 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.9) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.4 to 14.7) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.8) · 339 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 388 cases | No different | Jan 2024 – Dec 2024 |
What patients said (496 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for St Luke'S Regional Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.459 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.203 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.407 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6.8 to 9.7) · 1,092 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.61 (0.78 to 2.43) · 2,278 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.6 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.38 (95.48 to 183.27) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 345 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 796 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,937 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,027 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.85 to 5.1) · 2,997 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0 to 2.7) · 1,577 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.25 to 3.8) · 2,793 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (1.86 to 10.74) · 1,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.15 to 7.42) · 1,483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.4 (0.03 to 2.76) · 843 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 7,363 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 124 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.938 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.1 · 607 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.8 · 965 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3 · 373 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -48.3 · 559 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.7 · 546 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 901 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.4) · 1,092 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.2) · 361 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 2,189 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,628 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$59,221
Medicare paid this office $59,221 for 1,218 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 130 | $11,057 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 225 | $10,249 | $46 |
| Return visit (30+ min) | 84 | $6,130 | $64 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,027 | $377 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 696 | $4,896 | $5 |
See all 17 services
| New patient visit (45+ min) | 130 | $11,057 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 225 | $10,249 | $46 |
| Return visit (30+ min) | 84 | $6,130 | $64 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $6,027 | $377 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 696 | $4,896 | $5 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $3,680 | $127 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 27 | $3,309 | $123 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 69 | $1,001 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $982 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $790 | $61 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 34 | $563 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $403 | $8 |
| Ultrasound of heart, follow-up | 21 | $402 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 56 | $283 | $5 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $227 | $9 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $93 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $39 | $2 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 33 | More than 68% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,218 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 15% · Women 53% · Also on Medicaid 9% · Health risk score 1.45. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 36% · Atrial fibrillation 36% · Diabetes 33% · Heart failure 30% · Chronic kidney disease 30% · Depression 29% · COPD 19% · Cancer 18% · Stroke 12% · Dementia 11%.
The office billed $204,460, Medicare allowed $80,387 and paid $59,221; for 1,816 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,218 | 1,816 | 75 | 1.45 | $204,460 | $59,221 |
| 2023 | 1,533 | 2,271 | 75 | 1.55 | $254,667 | $75,195 |
| 2022 | 1,969 | 2,907 | 74 | 1.57 | $261,536 | $83,402 |
| 2021 | 130 | 250 | 75 | 1.38 | $56,876 | $19,554 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 267 | $11,589 | $43 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $10,661 | $355 |
| New patient visit (45+ min) | 93 | $8,627 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $7,607 | $129 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 967 | $7,346 | $6 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 14 | $6,577 | $470 |
| Return visit (30+ min) | 75 | $5,316 | $65 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $3,777 | $145 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $3,424 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,278 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,132 | $54 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $885 | $68 |
| Ultrasound of heart, follow-up | 36 | $624 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 57 | $522 | $9 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 89 | $517 | $6 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $475 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 34 | $461 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $164 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $135 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $60 | $2 |
2022: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 331 | $16,054 | $48 |
| New patient visit (45+ min) | 121 | $11,041 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,356 | $9,709 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $9,066 | $144 |
| Return visit (30+ min) | 90 | $8,268 | $63 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $6,504 | $407 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,183 | $167 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $1,866 | $124 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 91 | $1,403 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,395 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,254 | $57 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $819 | $68 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 30 | $588 | $20 |
| Ultrasound of heart, follow-up | 31 | $574 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 91 | $469 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $428 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $197 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $72 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $39 | $2 |
2021: 5 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $3,622 | $53 |
| New patient visit (45+ min) | 24 | $2,356 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,102 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,078 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $217 | $9 |
Medicaid work
$3,645 in 2024
Medicaid paid $3,645 for 738 billed services this clinician did in 2024, up to 299 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 738 | $3,645 |
| 2024 | 738 | 1 | 299 | $3,645 |
| 2023 | 986 | 2 | 270 | $6,467 |
| 2022 | 1,730 | 4 | 316 | $16,762 |
| 2021 | 12 | 1 | 12 | $460 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 934 | $4,415 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 52 | $2,051 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,518 | $8,054 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 170 | $6,692 |
| New patient visit (45+ min) | 28 | $1,828 |
| CARDIOVASCULAR STRESS TEST | 14 | $189 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $460 |
Drugs they prescribed that Part D paid
$367,350
Pharmacies billed $367,350 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,870) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
1,558 generic and 312 brand-name prescriptions · $367,350 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 209 | $246,321 | $1,179 |
| Xarelto | 17 | $17,358 | $1,021 |
| Farxiga | 15 | $15,430 | $1,029 |
| Nexletol | 12 | $10,897 | $908 |
| Metoprolol | 258 | $3,204 | $12 |
See all 24 drugs
| Eliquis | 209 | $246,321 | $1,179 |
| Xarelto | 17 | $17,358 | $1,021 |
| Farxiga | 15 | $15,430 | $1,029 |
| Nexletol | 12 | $10,897 | $908 |
| Metoprolol | 258 | $3,204 | $12 |
| Atorvastatin | 195 | $2,507 | $13 |
| Losartan | 83 | $1,069 | $13 |
| Clopidogrel | 66 | $1,018 | $15 |
| Telmisartan | 39 | $979 | $25 |
| Diltiazem 24hr Er (Cd) | 37 | $957 | $26 |
| Ezetimibe | 41 | $935 | $23 |
| Spironolactone | 109 | $877 | $8 |
| Lisinopril | 73 | $838 | $11 |
| Nitroglycerin | 25 | $809 | $32 |
| Furosemide | 157 | $801 | $5 |
| Isosorbide Mononitrate Er | 40 | $721 | $18 |
| Rosuvastatin | 57 | $719 | $13 |
| Carvedilol | 66 | $680 | $10 |
| Metoprolol | 77 | $631 | $8 |
| Pravastatin | 35 | $566 | $16 |
| Amlodipine Besylate | 51 | $351 | $7 |
| Potassium Chloride | 12 | $201 | $17 |
| Warfarin | 15 | $124 | $8 |
| Hydrochlorothiazide | 21 | $64 | $3 |
Year by year
| 2024 | 1,870 | 365 | 0% (0) | 17% | $367,350 |
| 2023 | 1,634 | 333 | 0% (0) | 14% | $285,730 |
| 2022 | 1,083 | 208 | 0% (0) | 13% | $145,084 |
| 2021 | 236 | 73 | 0% (0) | 11% | $20,366 |
| 2020 | 109 | 47 | 0% (0) | None | $2,918 |
| 2019 | 91 | 23 | 0% (0) | None | $1,122 |
| 2018 | 77 | 23 | 0% (0) | 16% | $5,568 |
| 2017 | 19 | None | 0% (0) | None | $2,294 |
| 2016 | 17 | None | 0% (0) | None | $239 |
| 2015 | 26 | 13 | 0% (0) | None | $1,279 |
| 2014 | 29 | None | 0% (0) | None | $362 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 165 | $213,142 | $1,292 |
| Xarelto | 12 | $14,248 | $1,187 |
| Metoprolol | 208 | $4,744 | $23 |
| Atorvastatin | 211 | $3,505 | $17 |
| Diltiazem 24hr Er (Cd) | 48 | $2,752 | $57 |
| Losartan | 116 | $1,973 | $17 |
| Ezetimibe | 23 | $1,306 | $57 |
| Carvedilol | 84 | $1,213 | $14 |
| Potassium Chloride | 24 | $1,209 | $50 |
| Rosuvastatin | 29 | $1,181 | $41 |
| Isosorbide Mononitrate Er | 30 | $921 | $31 |
| Clopidogrel | 53 | $917 | $17 |
| Cartia Xt | 12 | $867 | $72 |
| Spironolactone | 99 | $826 | $8 |
| Furosemide | 96 | $766 | $8 |
| Lisinopril | 107 | $717 | $7 |
| Metoprolol | 59 | $676 | $11 |
| Warfarin | 26 | $574 | $22 |
| Pravastatin | 22 | $556 | $25 |
| Amlodipine Besylate | 40 | $259 | $6 |
| Nitroglycerin | 18 | $219 | $12 |
| Hydrochlorothiazide | 34 | $144 | $4 |
2022: 18 drugs
| Eliquis | 94 | $117,111 | $1,246 |
| Metoprolol | 138 | $2,951 | $21 |
| Atorvastatin | 130 | $1,896 | $15 |
| Potassium Chloride | 40 | $1,442 | $36 |
| Carvedilol | 76 | $1,045 | $14 |
| Rosuvastatin | 17 | $985 | $58 |
| Isosorbide Mononitrate Er | 35 | $836 | $24 |
| Losartan | 51 | $792 | $16 |
| Diltiazem 24hr Er (Cd) | 17 | $540 | $32 |
| Furosemide | 103 | $540 | $5 |
| Warfarin | 22 | $522 | $24 |
| Clopidogrel | 31 | $513 | $17 |
| Spironolactone | 54 | $430 | $8 |
| Metoprolol | 39 | $364 | $9 |
| Pravastatin | 16 | $363 | $23 |
| Lisinopril | 51 | $293 | $6 |
| Amlodipine Besylate | 34 | $250 | $7 |
| Hydrochlorothiazide | 16 | $65 | $4 |
2021: 5 drugs
| Eliquis | 16 | $14,860 | $929 |
| Clopidogrel | 69 | $729 | $11 |
| Atorvastatin | 32 | $438 | $14 |
| Metoprolol | 27 | $301 | $11 |
| Furosemide | 12 | $25 | $2 |
2020: 2 drugs
| Clopidogrel | 23 | $317 | $14 |
| Atorvastatin | 16 | $187 | $12 |
2019: 3 drugs
| Potassium Chloride | 11 | $326 | $30 |
| Furosemide | 21 | $182 | $9 |
| Spironolactone | 14 | $60 | $4 |
Money from drug and device companies
$253 in 2025
| 2025 | 4 | 5 | None | $253 |
| 2024 | 5 | 6 | None | $192 |
| 2023 | 3 | 4 | None | $87 |
| 2022 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $167 | 1 payment
|
| Abiomed | None | $43 | 2 payments
|
| Boston Scientific | Rotapro | $26 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $17 | 1 payment
|
See all 5 published payments
| Shockwave Medical | Meals · 2025-10-14 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $167 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-09-16 | Lifevest | $17 |
| Abiomed | Meals · 2025-07-22 | None | $27 |
| Abiomed | Meals · 2025-05-30 | None | $16 |
| Boston Scientific | Meals · 2025-03-05 | Rotapro | $26 |
See earlier years (2024, 2023, 2022)
2024: $192
| Heartflow | Ffrct | $90 | 1 payment
|
| Abiomed | Impella | $48 | 2 payments
|
| Getinge USA Sales | Cs300 Intra-Aortic Balloon Pump, English, 110v | $20 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
2023: $87
| Abiomed | Impella | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Amgen | Repatha | $19 | 1 payment
|
2022: $15
| Abiomed | Impella | $15 | 1 payment
|
Professional record
- NPI
- 1588001242
- Licence
- ID M-15745
- Trained
- University of Washington School of Medicine, 2013
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Student in a training program (390200000X)
- Mailing address
- 9850 W St Lukes Dr Ste 180, Nampa, ID, 83687
- NPI first listed
- 2013-06-03
- NPI last updated
- 2021-06-09
- NPI record certified
- 2021-06-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 710 Lawrence Expy, Santa Clara, CA, 95051